VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share (VYNE)

Historical Holders from Q1 2023 to Q2 2025

Symbol
VYNE on Nasdaq
CUSIP
92941V308
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
16.7M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
8.05M
Holdings value
$13.3M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
44
Number of buys
22
Number of sells
-19
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share (VYNE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EVENTIDE ASSET MANAGEMENT, LLC 9.99% $592K 1.85M Eventide Asset Management, LLC Jun 30, 2025
Cormorant Asset Management, LP 8.23% -17.6% $439K -$153K 1.37M -25.9% Cormorant Asset Management, LP Jun 30, 2025
CITADEL ADVISORS LLC 7.2% $1.63M 1.1M Kenneth Griffin Mar 31, 2025

Institutional Holders of VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share (VYNE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 8.05M $13.3M +$1.5M $1.65 44
2025 Q1 7.11M $11.4M -$2.38M $1.58 36
2024 Q4 7.03M $23.3M +$606K $3.35 34
2024 Q3 7.31M $14.3M -$1.23M $1.88 30
2024 Q2 7.94M $16M +$243K $1.97 29
2024 Q1 6.4M $19.7M +$378K $3.07 28
2023 Q4 1.04K $2.43K $2.33 1
2023 Q3 359K $1.44M -$33.7K $4.04 19
2023 Q2 375K $1.53M +$203K $4.10 18
2023 Q1 334K $1.03M +$1.03M $3.08 18